Matthew Paul Kowalsky - Apr 29, 2024 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Signature
/s/ Matthew Paul Kowalsky
Stock symbol
ENTA
Transactions as of
Apr 29, 2024
Transactions value $
$0
Form type
4
Date filed
5/1/2024, 04:27 PM
Previous filing
Aug 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTA Stock Option (right to buy) Award $0 +150K $0.00 150K Apr 29, 2024 Common Stock 150K $13.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of such option will become exercisable on April 29, 2025 (the "Anniversary Date"), with the remainder to become exercisable quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over three years from the Anniversary Date (in each case subject to the optionholder's continued employment).